A PYMNTS Company

Antitrust remedies: in search of a balanced dosage

By  |  October 2, 2017

By Eduardo Caminati Anders & Guilherme Teno Castillho Misale

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The assessment of antitrust remedies under the merger control realm has been raising noteworthy reflections worldwide, and one clear-cut challenge in this strand concerns the gauging of remedies to achieve an adequate and balanced dosage so as to avoid perverse effects. Ultimately, the remedy can turn itself into poison (sola dosis facit venenum) if not well-structured.

    Download Full Article: Here

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.